NCT07020923View on ClinicalTrials.gov

Monthly Dosing of Atacicept in IgAN

PHASE2RecruitingINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

May 29, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions

IgA Nephropathy (IgAN)Berger Disease

Interventions

DRUG

Atacicept

Drug: Atacicept

Trial Locations (1)

94005

RECRUITING

Vera Therapeutics, Brisbane

All Listed Sponsors

lead

Vera Therapeutics, Inc.

INDUSTRY